Try it
Psychiatry · Psychopharmacology: SSRI of choice in cardiac disease
Sample itemIn a patient with depression after a myocardial infarction, which antidepressant has the best safety evidence?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Sertraline
Sertraline was shown to be safe in post-MI and unstable angina patients in randomised trials (SADHART). TCAs cause arrhythmias, citalopram prolongs QT in high doses, and venlafaxine can raise blood pressure.
Option by option
A. Sertraline (correct)
Correct. Sertraline is the preferred drug in ischaemic heart disease.
B. Citalopram at high dose
High-dose citalopram prolongs QTc.
C. Venlafaxine at high dose
High-dose venlafaxine raises blood pressure.
D. Amitriptyline
TCAs are proarrhythmic.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Psychiatry questions
- PsychopharmacologyLithium use during the first trimester of pregnancy is associated with which congenital…
- Psychotic disordersWhich of the following is a Schneiderian first-rank symptom of schizophrenia?
- Organic psychiatryAn elderly patient on a surgical ward develops acute confusion that fluctuates through t…
- Eating disordersA 17-year-old girl has a BMI of 15, amenorrhoea, lanugo hair, bradycardia and an intense…